Hans C. van Mierlo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hans C. van Mierlo has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Jasper C.A. Broen
Laboratory of Translational Immunology, Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
3 shared publicationsChristiaan H. Vinkers
Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publicationsLot D. de Witte
Department of Psychiatry, Icahn School of Medicine, New York, United States; Mental Illness Research, Education and Clinical Center (MIRECC), James J Peters VA Medical Center, Bronx, NY, United States
2 shared publications- Lot D. de Witte
Department of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht (BCRM-UMCU), Utrecht University, P.O. Box 85500, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands
2 shared publications Lot de Witte
Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications- Maarten J. Titulaer
Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands
2 shared publications
Latest Publications
- 1 October 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 81, 52-62
B-cells and schizophrenia: A promising link or a finding lost in translation?
- 1 October 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 81, 52-62
B-cells and schizophrenia: A promising link or a finding lost in translation?
- 1 December 2017
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 95, 231-234
Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia
- 1 December 2017
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 95, 231-234
Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia
- 1 November 2017
- Published by Elsevier in Schizophrenia Research
- Vol. 189, 210-212
Clinical consequences of extensive routine laboratory investigations in patients with a recent onset psychotic disorder
- 1 November 2017
- Published by Elsevier in Schizophrenia Research
- Vol. 189, 210-212
Clinical consequences of extensive routine laboratory investigations in patients with a recent onset psychotic disorder
- 1 December 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (12) , 2326-2332
No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia
- 1 December 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (12) , 2326-2332
No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia
- Open Access
- 4 November 2015
- Published by Springer Nature in Schizophrenia
- Vol. 1 (1) , 15041
The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study
Background: Exposure to neurotropic pathogens has been proposed as an environmental risk factor for schizophrenia and can be evaluated by measuring pathogen-specific immunoglobulin G (IgG). Seroprevalence of pathogen-specific IgG reflects prior exposure, whereas IgG levels are associated with reactivity or reinfection. Several studies have examined these parameters in schizophrenia. However, results still remain inconclusive, as several previous studies did not correct for important confounding factors. Aims: To investigate whether schizophrenia is associated with prior exposure to neurotropic pathogens, or with their reactivation. Methods: We examined the seroprevalence and titer of IgG antibodies against herpes simplex virus-1 and -2 (HSV-1/HSV-2), varicella zoster virus (VZV), Epstein–Barr virus (EBV), cytomegalovirus (CMV), and Toxoplasma gondii (TG) in plasma of 368 adult patients with a schizophrenia spectrum disorder and 282 controls using ELISA. Results: We did not find evidence for an increased exposure to HSV-1, HSV-2, EBV, and TG in patients. There was a significantly higher seroprevalence of VZV (98.9% vs. 95.6%, PP<0.001) in controls as compared with patients, which did not remain statistically significant after adjustment for various potential confounders. We did not find significant differences in antibody titers of seropositive patients and controls for any of the six pathogens. Conclusions: Our results do not support the hypothesis that increased exposure to neurotropic pathogens after birth is associated with schizophrenia.
- 4 November 2015
- Published by Springer Nature in Schizophrenia
- Vol. 1 (1) , 15041
Open AccessThe association between antibodies to neurotropic pathogens and schizophrenia: a case-control study
Background: Exposure to neurotropic pathogens has been proposed as an environmental risk factor for schizophrenia and can be evaluated by measuring pathogen-specific immunoglobulin G (IgG). Seroprevalence of pathogen-specific IgG reflects prior exposure, whereas IgG levels are associated with reactivity or reinfection. Several studies have examined these parameters in schizophrenia. However, results still remain inconclusive, as several previous studies did not correct for important confounding factors. Aims: To investigate whether schizophrenia is associated with prior exposure to neurotropic pathogens, or with their reactivation. Methods: We examined the seroprevalence and titer of IgG antibodies against herpes simplex virus-1 and -2 (HSV-1/HSV-2), varicella zoster virus (VZV), Epstein–Barr virus (EBV), cytomegalovirus (CMV), and Toxoplasma gondii (TG) in plasma of 368 adult patients with a schizophrenia spectrum disorder and 282 controls using ELISA. Results: We did not find evidence for an increased exposure to HSV-1, HSV-2, EBV, and TG in patients. There was a significantly higher seroprevalence of VZV (98.9% vs. 95.6%, PP<0.001) in controls as compared with patients, which did not remain statistically significant after adjustment for various potential confounders. We did not find significant differences in antibody titers of seropositive patients and controls for any of the six pathogens. Conclusions: Our results do not support the hypothesis that increased exposure to neurotropic pathogens after birth is associated with schizophrenia.
- 15 September 2015
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 132 (4) , 312-313
Early recognition of anti‐N‐methyl‐D‐aspartate receptor encephalitis in psychiatric patients
- 15 September 2015
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 132 (4) , 312-313
Early recognition of anti‐N‐methyl‐D‐aspartate receptor encephalitis in psychiatric patients
- Open Access
- 1 July 2015
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (7) , 731-733
Absence ofN-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia
This research letter investigates the presence of anti-GluN1 IgG autoantibodies in 475 patients with a schizophrenia spectrum disorder and includes the cross-va
- 1 July 2015
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (7) , 731-733
Open AccessAbsence ofN-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia
This research letter investigates the presence of anti-GluN1 IgG autoantibodies in 475 patients with a schizophrenia spectrum disorder and includes the cross-va
- Open Access
- 6 May 2015
- Published by Springer Nature in Schizophrenia
- Vol. 1 (1) , 15013
The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study
Npj Schizophrenia publishes high-quality research relevant to all aspects of schizophrenia and psychosis. The journal is fully open access and published in partnership by Nature Publishing Group and the Schizophrenia International Research Society.
- 6 May 2015
- Published by Springer Nature in Schizophrenia
- Vol. 1 (1) , 15013
Open AccessThe prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study
Npj Schizophrenia publishes high-quality research relevant to all aspects of schizophrenia and psychosis. The journal is fully open access and published in partnership by Nature Publishing Group and the Schizophrenia International Research Society.
- 1 January 2015
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 51, 506-512
Longitudinal changes of telomere length and epigenetic age related to traumatic stress and post-traumatic stress disorder
- 1 January 2015
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 51, 506-512
Longitudinal changes of telomere length and epigenetic age related to traumatic stress and post-traumatic stress disorder